Profile data is unavailable for this security.

About the company

EssilorLuxottica SA, formerly known as Essilor International Compagnie Generale D Optique SA, is a France-based ophthalmic company. The Company designs, manufactures and markets a range of lenses, frames and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. The Company operates under a number of brands, including Ray-Ban, Oakley and Varilux, among others. The Company operates in Europe, North America, Asia Pacific, the Middle East, Africa and Latin America.

  • Revenue in EUR (TTM)15.01bn
  • Net income in EUR1.23bn
  • Incorporated1993
  • Employees150.62k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EL:PAR since
GrandVision NVAnnounced17 Jul 201917 Jul 2019Announced17.55%6.20bn
Brille24 GmbHDeal completed11 Feb 201911 Feb 2019Deal completed30.64%--
Data delayed at least 15 minutes, as of Jan 24 2020 16:35 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Sonova Holding AG2.70bn578.40m14.58bn14.99k25.326.8919.775.419.579.5744.5835.190.663.146.75195,806.3014.3011.3218.4914.0171.2569.2521.6616.270.722473.050.229841.084.437.2113.495.914.498.83
Straumann Holding AG1.37bn269.85m14.93bn6.68k55.3412.8244.0310.9418.2018.2092.0878.560.7421.884.41245,572.0014.7915.8318.4618.3375.3376.7219.9320.791.0414.600.283434.1222.6114.93-2.4221.9354.056.96
Sartorius Stedim Biotech SA1.34bn237.95m15.03bn5.95k62.9713.6849.1411.262.592.5914.5411.920.83522.585.63236,961.5014.9712.4720.3316.5951.5950.8917.9314.710.776624.450.133725.8512.1315.5529.1525.7143.2423.30
Smith & Nephew plc4.47bn631.01m20.03bn16.00k31.774.4719.224.480.60760.60764.314.310.59420.89673.98230,312.708.388.6210.0210.4773.8774.2114.1013.380.961315.190.305645.332.922.42-17.023.580.40845.19
Coloplast A/S2.40bn518.28m22.72bn12.07k47.1726.3537.539.4618.1818.1884.1932.541.463.165.951,485,755.0031.6227.2052.1647.2267.7567.9621.5919.820.895649.550.1488100.879.067.620.728210.145.308.13
Koninklijke Philips NV19.11bn1.36bn40.90bn79.61k31.24--,899.20--2.44--3.5646.3443.807.133.81--18.74--114.411.92-3.8060.074.79-0.32891.22
Siemens Healthineers AG14.52bn1.57bn45.10bn52.00k28.864.6120.433.111.561.5614.499.780.7054.484.37279,192.307.70--10.49--39.92--10.92--1.0229.050.0143--8.11--23.87------
EssilorLuxottica SA15.01bn1.23bn60.82bn150.62k43.131.8022.624.053.223.2242.5577.250.4953.536.7699,630.854.456.615.438.7161.1560.759.0012.350.733720.520.155740.8517.5816.354.5212.8819.0416.76
Data as of Jan 24 2020. Currency figures normalised to EssilorLuxottica SA's reporting currency: Euro EUR

Institutional shareholders

11.41%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 31 Dec 20199.95m2.28%
The Vanguard Group, Inc.as of 31 Dec 20198.52m1.95%
Norges Bank Investment Managementas of 31 Dec 20185.97m1.37%
Massachusetts Financial Services Co.as of 30 Nov 20194.45m1.02%
Capital Research & Management Co. (Global Investors)as of 31 Dec 20194.23m0.97%
BlackRock Fund Advisorsas of 09 Jan 20204.22m0.96%
Amundi Asset Management SA (Investment Management)as of 31 Dec 20184.03m0.92%
WCM Investment Management LLCas of 16 Jan 20202.93m0.67%
Baillie Gifford & Co.as of 16 Jan 20202.92m0.67%
Comgest SAas of 30 Sep 20192.68m0.61%
More ▼
Data from 31 Dec 2018 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.